{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:44:36Z","timestamp":1762868676399,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.htct.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T04:37:26Z","timestamp":1589344646000},"page":"200-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel \u2013 ABHH monoclonal gammopathies committe"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4327-1957","authenticated-orcid":false,"given":"Vania","family":"Hungria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Garnica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvan de Queiroz","family":"Cruso\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Jose Pessoa de","family":"Magalhaes Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gracia","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Le\u00e3o Cordeiro de","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter Moises","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Vaz Pinto","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glaciano Nogueira","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-9548","authenticated-orcid":false,"given":"Angelo","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2020.05.001_bib0005","unstructured":"World Health Organization. Coronavirus diasease 2019 (COVID-19) Situation report 99. Internet. Available from: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200428-sitrep-99-covid-19.pdf?sfvrsn=119fc381_2."},{"key":"10.1016\/j.htct.2020.05.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(20)30123-X","article-title":"Effect of the COVID-19 pandemic on cancer treatment and research","author":"Saini","year":"2020","journal-title":"Lancet Haemalol"},{"issue":"8","key":"10.1016\/j.htct.2020.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"Nucci","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.htct.2020.05.001_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infectious: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.htct.2020.05.001_bib0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.clml.2017.02.025","article-title":"Clinical and serologic responses following a two dose series of high-dose influenza vaccine in plasma cell disorders: a prospective, single-arm trial","volume":"17","author":"Branagan","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.htct.2020.05.001_bib0030","unstructured":"International Myeloma Foundation. Are Myeloma Patients Really at a Higher Risk if Infected with COVID-19? (April 30, 2020 UPDATE). Internet. Available from: https:\/\/www.myeloma.org\/cure-blog\/are-myeloma-patients-really-higher-risk-if-infected-covid-19-0."},{"key":"10.1016\/j.htct.2020.05.001_bib0035","article-title":"Viral dynamic in mild and severe cases of COVID-19","author":"Liu","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.htct.2020.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"issue":"4","key":"10.1016\/j.htct.2020.05.001_bib0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-10 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.htct.2020.05.001_bib0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical Characteristics of Covid-19 in New York City","author":"Goyal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2020.05.001_bib0055","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.htct.2020.05.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.062","article-title":"The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis","author":"Yang","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.htct.2020.05.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00512-20","article-title":"The laboratory diagnosis of COVID-19 infection: current issues and challenges","author":"Tang","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.htct.2020.05.001_bib0070","article-title":"Antibody detection and dynamic characteristics in patients with COVID-19","author":"Xiang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.htct.2020.05.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19) a review","author":"Sanders","year":"2020","journal-title":"JAMA"},{"issue":"10234","key":"10.1016\/j.htct.2020.05.001_bib0080","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.htct.2020.05.001_bib0085","article-title":"Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis","author":"Ciceri","year":"2020","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.htct.2020.05.001_bib0090","article-title":"Developing Covid-19 vaccines at pandemic speed [published online ahead of print, 2020 Mar 30","author":"Lurie","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2020.05.001_bib0095","article-title":"Unknown unknowns - COVID-19 and potential global mortality","volume":"144","author":"Grech","year":"2020","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.htct.2020.05.001_bib0100","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa468","article-title":"Responding to the COVID-19 outbreak in Singapore: staff protection and staff temperature and sickness surveillance systems","author":"Htun","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.htct.2020.05.001_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.04.002","article-title":"Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre","author":"Peiffer-Smadja","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.htct.2020.05.001_bib0110","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.htct.2020.05.001_bib0115","article-title":"Universal masking in hospital in the COVID-19 era","author":"Klompas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2020.05.001_bib0120","first-page":"1","article-title":"Multiple myeloma in the time of COVID-19 acta haematol","volume":"17","author":"Al Saleh","year":"2020","journal-title":"Acta Haematol"},{"key":"10.1016\/j.htct.2020.05.001_bib0125","article-title":"Management of patients with multiple myeloma during the COVID-19 pandemic lancet haematol","author":"Malard","year":"2020","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.htct.2020.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.2019000241","article-title":"Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma","volume":"134","author":"Rosi\u00f1ol","year":"2019","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.htct.2020.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.htct.2020.05.001_bib0140","unstructured":"European Society for Blood and Marrow Transplantation 154 (EBMT). COVID-19 and BMT. Internet. Available from: https:\/\/www.ebmt.org\/covid-19-and-bmt [cited 30.3.20]."},{"issue":"7","key":"10.1016\/j.htct.2020.05.001_bib0145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1470-2045(18)30354-1","article-title":"Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study","volume":"19","author":"Moreau","year":"2018","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.htct.2020.05.001_bib0150","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2020.05.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp2009249","article-title":"Mild or moderate COVID-19","author":"Gandhi","year":"2020","journal-title":"NEJM"},{"issue":"2","key":"10.1016\/j.htct.2020.05.001_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.leu.2405062","article-title":"Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma","volume":"22","author":"Palumbo","year":"2008","journal-title":"Leukemia"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137920300547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137920300547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:31:34Z","timestamp":1762867894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137920300547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2531137920300547"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2020.05.001","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel \u2013 ABHH monoclonal gammopathies committe","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}